Abstract
Acute lymphoblastic leukemia (ALL) is one of the most hematological malignancies of lymphoid origin. It has been proposed that deregulation of cytokines could be linked with pathogenesis, progression, and survival in many diseases. Genetic polymorphisms in two important cytokines like tumor necrosis factor-α (TNF-α) −308 and lymphotoxin-α (LT-α) +252 can disturb both their transcription and expression and lead to their high plasma levels. A difference in the occurrence of the polymorphisms in TNF-α −308 G/A and LT-α +252 A/G in ALL cases among several populations with different ethnicities was observed. The study investigated the occurrence and the role of polymorphisms of tumor necrosis factor genes including TNF-α −308 G>A and LT-α +252 A>G in the development of ALL in Egypt. A case-control study was done on 126 newly diagnosed ALL patients (96 pediatric and 30 adult patients); 130 healthy subjects composed the control group. Polymorphism variants of TNF-α and LT-α genes were studied by PCR-RFLP on genomic DNA of all studied individuals. TNF-α −308 G/A polymorphism was statistically significant in ALL pediatric patients (P value = 0.008) with no association with ALL adult patients. TNF AA homozygous variant genotype and the A allele both showed significant risks of the development of pediatric ALL. However, there was no association between LT-α +252 A/G polymorphism in both pediatric and adult ALL. The results show that TNF AA homozygous variant genotype and A allele showed a significant risk of development of pediatric ALL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bhojwani D, Yang JJ, Pui CH (2015) Biology of childhood acute lymphoblastic leukemia. Pediatr Clin N Am 62(1):47–60. https://doi.org/10.1016/j.pcl.2014.09.004
Bogunia-Kubik K, Mazur G, Urbanowicz I, Wróbel T, Kuliczkowski K, Woźniak M, Lange A (2006) Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet 33(1):21–24. https://doi.org/10.1111/j.1744-313X.2005.00553.x
Cao C, Liu S, Lou SF, Liu T (2014) The +252A/G polymorphism in the lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis. Eur Rev Med Pharmacol Sci 18(4):544–552
Figgett WA, Vincent FB, Saulep-Easton D, Mackay F (2014) Roles of ligands from the TNF superfamily in B cell development, function, and regulation. Semin Immunol 26(3):191–202. https://doi.org/10.1016/j.smim.2014.06.001
Fulda S (2014) Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Adv Exp Med Biol 818:167–180. https://doi.org/10.1007/978-1-4471-6458-6_8
He YQ, Zhu JH, Huang SY, Cui Z, He J, Jia WH (2014) The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis. Tumour Biol 35(12):12509–12517. https://doi.org/10.1007/s13277-014-2569-6
Ibrahim A, Abdel Rahman H, Khorshied M, Rania S, Nasr N, Khorshid O (2012) Tumor necrosis factor alpha-308 and lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res 36(6):694–698. https://doi.org/10.1016/j.leukres.2011.11.016
Inaba H, Greaves M, Mullighan CG (2013) Acute lymphoblastic leukaemia. Lancet 381(9881):1943–1955. https://doi.org/10.1016/S0140-6736(12)62187-4
Jevtovic-Steimenov T, Kocic G, Pavlovic D, Macukanovic-Golubovic L, Marjanovic G, Djordjevic V et al (2008) Polymorphisms of tumor-necrosis factor alpha−308 and lymphotoxin-alpha+250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma 49(11):2163–2169. https://doi.org/10.1080/10428190802381220
Kidas E, Moricke A, Beier R, Welte K, Schrappe M, Stanulla M et al (2009) Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study. Int J Hematol 89(5):584–591. https://doi.org/10.1007/s12185-009-0285-6
Lacour B, Clavel J (2014) Epidemiological aspects of childhood cancer. Rev Prat 64(9):1264–1269
Mullighan CG (2012) The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2012:389–396. https://doi.org/10.1182/asheducation-2012.1.389
Mullighan CG (2013) Genomic characterization of childhood acute lymphoblastic leukemia. Semin Hematol 50(4):314–324
Nasiri H, Farajnia S, Rezamand A, Movassaghpour AA, Esmaeili HA, Monfaredan A, Mobarra N, Rahimifar N, Sahebi L, Farshdousti Hagh M (2013) Genetic variations of tumor necrosis factor-α-308 and lymphtoxin-α+252 in non-Hodgkin lymphoma and acute lymphoblastic leukemia patients. Iran J Basic Med Sci 16(9):990–995
Ofran Y, Rowe JM (2014) Acute myeloid leukemia in adolescents and young adults: challenging aspects. Acta Haematol 132(3–4):292–297. https://doi.org/10.1159/000360200
Rickert RC, Jellusova J, Miletic AV (2011) Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 244(1):115–133. https://doi.org/10.1111/j.1600-065X.2011.01067.x
Šedý J, Bekiaris V, Ware CF (2014) Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harb Perspect Biol 7(4):a016279. https://doi.org/10.1101/cshperspect.a016279
Skibola CF, Bracci PM, Nieters A, Brooks WA, Sanjos S, Hughes AM et al (2009) Tumor necrosis factor (TNF) and lymphotoxin-a (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171:267–276
Stanulla M, Schrauder A, Welte K, Schrappe M (2001) Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy. BMC Blood Disord 1(1):2
Takeuchi S, Takeuchi N, Tsukasaki K, Bartram CR, Zimmermann M, Schrappe M, Taguchi H, Koeffler HP (2002) Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia. Br J Hematol 119(4):985–957. https://doi.org/10.1046/j.1365-2141.2002.03964.x
Urayama KY, Manabe A (2014) Genomic evaluations of childhood acute lymphoblastic leukemia susceptibility across race/ethnicities. Rinsho Ketsueki 55(10):2242–2248
Yang L, Chen X, Liu H, Chen Y, Zhao Y, Bu D, Zhu P (2015) Donors with HLA-B*58:01/TNFα − 308A haplotype are unfavorable to haploidentical hematopoietic stem cell transplantation in acute lymphoblastic leukemia. Transpl Immunol 32(2):92–98. https://doi.org/10.1016/j.trim.2014.12.003
Zabaglia LM, Ferraz MA, Pereira WN, Orcini WA, de Labio RW, Neto AC, Wisnieski F, de Oliveira JG, Smith MC, Payão SLM, Rasmussen LT (2015) Lack of association among TNF-a gene expression, -308 polymorphism (G > A) and virulence markers of Helicobacter pylori. J Venomous Anim Toxins Incl Trop Dis 21(1):54. https://doi.org/10.1186/s40409-015-0054-3
Zhao HY, Chen YX, Lin XB, Zhong XY, Zhong LY, Ou RM et al (2003) Relationship between tumor necrosis factor genetic polymorphisms and acute lymphocytic leukemia. Ai Zheng 22(8):861–866 (Abstract)
Zuckerman T, Rowe JM (2014) Pathogenesis and prognostication in acute lymphoblastic leukemia. F1000Prime Rep 6:59. 10.12703/P6-59 eCollection 2014
Acknowledgments
We would like to thank Dr. Eman Fawzi for his effort in statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Informed consent
Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.
Ethics committee approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics No: R/16.08.40., date: 25 Sep. 2016
Rights and permissions
About this article
Cite this article
Abd El-Aziz, S.M., Alkhiary, W., Mokhtar, N. et al. Tumor necrosis factor-α (TNF-α) −308 G/A and lymphotoxin-α (LT-α) +252 A/G genetic polymorphisms in Egyptian acute lymphoblastic leukemia. Comp Clin Pathol 27, 363–369 (2018). https://doi.org/10.1007/s00580-017-2600-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-017-2600-6